If you've had more than three UTIs in a year — or two in six months — "drink cranberry juice" is not a plan. Here's what the American Urological Association and American Academy of Family Physicians actually recommend, ranked by evidence strength, plus when telehealth can handle it and when it's time for urology.
Both the AUA/CUA/SUFU recurrent UTI guideline and the AAFP define recurrent UTI as three or more culture-confirmed UTIs in 12 months, or two or more in six months. The "culture-confirmed" part is important — some patients are treated for UTI based on symptoms alone and end up with two problems: the real infections, and symptom flares that aren't infections at all (pelvic floor, interstitial cystitis, urethral irritation, vulvar dermatitis).
If you think you have recurrent UTIs, ask for a urine culture on your next symptomatic episode. Without culture data, the prevention plan is less targeted.
A randomized controlled trial in JAMA Internal Medicine (Hooton et al., 2018) assigned premenopausal women with recurrent UTIs to drink either their usual amount of water or an extra 1.5 liters per day. Over 12 months, the hydration group had roughly half as many UTI episodes. This is one of the few prevention measures with strong randomized evidence — and it's free.
Target about 8–12 cups of water per day. You'll know you're in the right zone when your urine is consistently pale yellow.
One of the most effective interventions in this group. Vaginal estradiol or estriol — as a cream, tablet, or ring — restores vaginal and periurethral tissue health and shifts the microbiome back toward protective lactobacilli. The AUA guideline explicitly recommends it for recurrent UTI in peri- and postmenopausal women. Systemic absorption at vaginal doses is minimal, so it's considered safe even for many patients who avoid systemic hormone therapy.
When behavioral and non-antibiotic measures aren't enough, the AUA endorses low-dose prophylactic antibiotics:
All reduce UTI recurrence significantly in trials. Trade-offs: antibiotic resistance, C. diff risk over time, and side effects (nitrofurantoin has pulmonary and hepatic risks with long-term use and is avoided with reduced kidney function).
D-mannose is a simple sugar that's thought to block E. coli's fimbrial adhesion to the bladder wall. Several randomized trials — summarized in PubMed meta-analyses — suggest 2 grams daily reduces recurrence in women whose UTIs are predominantly E. coli. It's generally well-tolerated and doesn't drive antibiotic resistance, which makes it a reasonable first-line prevention step to try before moving to prophylactic antibiotics.
The 2023 Cochrane review of cranberry products found modest benefit in reducing UTI recurrence in women with a history of recurrent infection. Key points: the effect is small, it requires consistent daily use (not "I'll drink some when I feel one coming on"), and sugary cranberry cocktail isn't the form studied. Standardized proanthocyanidin (PAC) capsules of 36mg daily, or unsweetened cranberry juice, are the useful forms.
Urinating within 30 minutes after sex has physiologic plausibility (flushes periurethral bacteria) and is endorsed by the NIH/NIDDK and AAFP. Evidence is observational rather than randomized, but the intervention is free and risk-free — so it's a standard recommendation.
UTI vaccines — particularly oral MV140 (Uromune) — have completed phase 3 trials in Europe and show promising durability of protection (roughly 50% reduction in recurrence at 9 years in the published open-label follow-up). They are not yet FDA-approved in the U.S. but are available in several European countries via named-patient import programs. We'll update this post when there's a U.S. approval pathway.
Behavioral and non-antibiotic measures are long-term. Prophylactic antibiotics are typically 3–12 months, with reassessment. About 50% of patients who discontinue prophylaxis recur within 3–6 months, so some patients stay on longer.
Only if your provider has explicitly set up a patient-initiated self-start regimen with you and you have an active prescription for that purpose. Using random leftover antibiotics breeds resistance and masks the actual organism.
Evidence is mixed but the intervention is low-risk. Some patients find it helpful; large randomized trials haven't confirmed it.
Post-coital single-dose antibiotic prophylaxis, if your provider agrees. Voiding after sex + D-mannose is a reasonable non-prescription first step.
Not automatically. Uncomplicated recurrent cystitis can often be managed in primary care or via telehealth. See urology if you have red flags: blood between infections, flank pain, male sex, prior complicated UTI, or failure of first-line prevention.